Technology | December 23, 2009

Drug Reference Application Available for Android

December 24, 2009 – A clinical reference and pharmaceutical database application was released this week for the Google Android personal digital assistant (PDA) device.

Lexi-Comp ON-HAND for Android features Lexi-Drugs, a comprehensive pharmacology database. Users can create and store personalized user notes within each monograph, as well as diagnose, find treatment options, and identify drug interactions in seconds. Databases stored on the memory card allow for quick access to the equivalent of more than 65,000 printed pages of the most updated clinical information available on a smartphone.

The application allows users to view tables, charts, appendices, and images as they are seen in Lexi-Comp’s handbooks and Internet platforms. Also, downloading and updating the software is now done over the air, with no cords or syncing required.

With Lexi-Comp ON-HAND software, clinicians can link to FDA warnings, PubMed, and additional resources directly from their phone. Additional licensed resources include “Harrison’s Practice,” “The 5-Minute Clinical Consultant,” and “Stedman’s Medical Dictionary” for the “Health Professions and Nursing.”

This platform expands Lexi-Comp’s handheld solution, which also includes compatibility with the iPod touch, smartphones including iPhone, BlackBerry and Windows Mobile, as well as Palm, Pocket PC devices, and any device with Web browser capabilities.

For more information: www.lexi.com/pda/google-android

Related Content

Quantum Genomics Enrolls First Patient in QUORUM Phase IIb Study of Firibastat
News | Pharmaceuticals | June 14, 2019
Quantum Genomics announced the enrollment of the first patient in its QUORUM Phase IIb study of its lead clinical...
FDA Grants Priority Review for Vascepa sNDA
News | Pharmaceuticals | May 29, 2019
Amarin Corp. plc announced that its supplemental new drug application (sNDA) for Vascepa (icosapent ethyl) capsules has...
Vascepa Markedly Reduces First, Repeat and Total Cardiovascular Events
News | Pharmaceuticals | March 29, 2019
Taking a high dose of icosapent ethyl significantly reduces the occurrence of first, subsequent and total ischemic...
Bempedoic Acid Combination Tablet Significantly Lowers LDL-Cholesterol

Image courtesy of Esperion

News | Pharmaceuticals | March 25, 2019
Phase 3 results from Study 2, also known as CLEAR WISDOM, of bempedoic acid were recently presented at the American...
Aurobindo Pharma Adds to Nationwide Valsartan Blood Pressure Medication Recall
News | Pharmaceuticals | January 10, 2019
January 10, 2019 — Aurobindo Pharma USA Inc.
Mylan Expands Nationwide Recall of Valsartan Blood Pressure Medication
News | Pharmaceuticals | December 11, 2018
December 11, 2018 — Mylan Pharmaceuticals is expanding its consumer-level voluntary nationwide recall to include all
Farxiga Reduces Heart Failure Hospitalization, Cardiovascular Death for Type 2 Diabetes
News | Pharmaceuticals | November 15, 2018
AstraZeneca announced positive full results from the DECLARE-TIMI 58 cardiovascular (CV) outcomes trial (CVOT) for...
Vascepa and Statins Significantly Reduce Cardiovascular Events in the REDUCE-IT trial. #AHA #AHA18 #AHA2018
News | Pharmaceuticals | November 13, 2018
A study in the current edition of the New England Journal of Medicine shows that a particular treatment significantly...
Evolocumab Benefits High-Risk Patients With Established Cardiovascular and Chronic Kidney Disease
News | Pharmaceuticals | October 31, 2018
Amgen announced a new Repatha cardiovascular outcomes study (FOURIER) analysis evaluating the effects of Repatha (...
Overlay Init